Skip to main content

Advertisement

Log in

Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

To study anticancer activities of 68 plant polyphenols with different backbone structures and various substitutions and to analyze the structure–activity relationships.

Methods

Antiproliferative activity of 68 plant polyphenols on human liver cancer cells were screened by the 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide method. Structure–activity relationships were analyzed by comparison of their activities with selected structures. Cell cycle progression was assayed by flow cytometry analysis and apoptosis was analyzed by DNA fragment assay.

Results

Based on their backbone structures, 68 polyphenols were sub-classed to flavonoids (chalcones, flavanones, flavones and isoflavones), chromones and coumarins. The order of their potency to suppress the human liver cancer cells is chalcones > flavones > chromones > isoflavones > flavanones > coumarins. Chalcones comprise the most potent group with IC50 values ranging from 21.69 to 197 µM. Top nine most potent chalcones in the group have hydroxylation at 2′-carbon position in B-ring. Flavones ranked second in their potencies. Quercetin, 4-hydroxyflavone and luteolin are three hydroxyflavones with highest potencies in this group. Their IC50 values are 30.81, 39.29 and 71.17 µM, respectively. Chromones, isoflavones, flavanones and coumarins showed much lower potencies when compared to the first two groups with IC50 ranges of 61 to >400, 131 to >400, 138 to >400 and 360.85 to >400 µM, respectively. In mechanistic studies, the most potent chalcone, 2,2′-dihydroxychalcone could induce G2/M arrest and then apoptosis of the cancer cells.

Conclusions

An analysis of structure–activity relationship showed that following structures are required for their inhibitory potencies on human liver cancer cells: (1) of the six sub-classes of the polyphenols tested, the unique backbone structure of chalcones with a open C-ring; (2) within the chalcone group, hydroxyl substitution at 2′-carbon of B-ring; (3) hydroxyl substitution at 3′-carbon in B-ring of flavones. However, some other structures were found to decrease their potencies: e.g. substitutions by sugar moieties in flavones. These data are valuable for design and modification of new polyphenols, which could be potential antiproliferative agents of cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yugarani T, Tan BK, Teh M, Das NP (1992) Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 27:181–186

    Article  PubMed  CAS  Google Scholar 

  2. Kuhnau J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24:117–191

    CAS  Google Scholar 

  3. Haslam E, Lilley TH, Cai Y, Martin R, Magnolato D (1989) Traditional herbal medicines—the role of polyphenols. Planta Med 55:1–8

    Article  PubMed  CAS  Google Scholar 

  4. Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751

    PubMed  CAS  Google Scholar 

  5. Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D (2006) In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur J Cancer Prev 15:353–361

    Article  PubMed  CAS  Google Scholar 

  6. Lambert JD, Hong J, Yang GY, Liao J, Yang CS (2005) Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81:S284–S291

    Google Scholar 

  7. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ (2007) Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120:451–458

    Article  PubMed  CAS  Google Scholar 

  8. Zhang K, Chew M, Yang EB, Wong KP, Mack P (2001) Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 59:837–843

    PubMed  CAS  Google Scholar 

  9. Cabrera M, Simoens M, Falchi G, Lavaggi ML, Piro OE, Castellano EE, Vidal A, Azqueta A, Monge A, de Cerain AL, Sagrera G, Seoane G, Cerecetto H, Gonzalez M (2007) Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure–activity relationships. Bioorg Med Chem 15:3356–3367

    Article  PubMed  CAS  Google Scholar 

  10. De Vincenzo R, Scambia G, Benedetti Panici P, Ranelletti FO, Bonanno G, Ercoli A, Delle Monache F, Ferrari F, Piantelli M, Mancuso S (1995) Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure–activity relationships. Anticancer Drug Des 10:481–490

    PubMed  Google Scholar 

  11. Zhang K, Das NP (1994) Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. Biochem Pharmacol 47:2063–2068

    Article  PubMed  CAS  Google Scholar 

  12. Zhang K, Wong KP (1996) Inhibition of the efflux of glutathione S-conjugates by plant polyphenols. Biochem Pharmacol 52:1631–1638

    Article  PubMed  CAS  Google Scholar 

  13. Zhang K, Wong KP (1997) Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols. Biochem J 325(Pt 2):417–422

    PubMed  CAS  Google Scholar 

  14. Zhang K, Wong KP, Chow P (2003) Conjugation of chlorambucil with GSH by GST purified from human colon adenocarcinoma cells and its inhibition by plant polyphenols. Life Sci 72:2629–2640

    Article  PubMed  CAS  Google Scholar 

  15. Ye CL, Liu JW, Wei DZ, Lu YH, Qian F (2005) In vivo antitumor activity by 2′, 4′-dihydroxy-6′-methoxy-3′, 5′-dimethylchalcone in a solid human carcinoma xenograft model. Cancer Chemother Pharmacol 56:70–74

    Article  PubMed  CAS  Google Scholar 

  16. Won SJ, Liu CT, Tsao LT, Weng JR, Ko HH, Wang JP, Lin CN (2005) Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. Eur J Med Chem 40:103–112

    Article  PubMed  CAS  Google Scholar 

  17. Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ (2003) Cytotoxic 2′, 5′-dihydroxychalcones with unexpected antiangiogenic activity. Eur J Med Chem 38:179–187

    Article  PubMed  CAS  Google Scholar 

  18. Sabzevari O, Galati G, Moridani MY, Siraki A, O’Brien PJ (2004) Molecular cytotoxic mechanisms of anticancer hydroxychalcones. Chem Biol Interact 148:57–67

    Article  PubMed  CAS  Google Scholar 

  19. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A (2006) Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66:4410–4418

    Article  PubMed  CAS  Google Scholar 

  20. Kuo PC, Liu HF, Chao JI (2004) Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 279:55875–55885

    Article  PubMed  CAS  Google Scholar 

  21. Hung H (2007) Dietary quercetin inhibits proliferation of lung carcinoma cells. Forum Nutr 60:146–157

    Article  PubMed  Google Scholar 

  22. Rong Y, Yang EB, Zhang K, Mack P (2000) Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression. Anticancer Res 20:4339–4345

    PubMed  CAS  Google Scholar 

  23. Lim JH, Park JW, Min DS, Chang JS, Lee YH, Park YB, Choi KS, Kwon TK (2007) NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12:411–421

    Article  PubMed  CAS  Google Scholar 

  24. Moridani MY, Galati G, O’Brien PJ (2002) Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem Biol Interact 139:251–264

    Article  PubMed  CAS  Google Scholar 

  25. Ramanathan R, Tan CH, Das NP (1992) Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett 62:217–224

    Article  PubMed  CAS  Google Scholar 

  26. Craft CS, Xu L, Bergan RC (2007) Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells. Mol Pharmacol 73(1):235–242

    Article  PubMed  Google Scholar 

  27. Perabo FG, Von Low EC, Ellinger J, von Rucker A, Muller SC, Bastian PJ (2007) Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 11(1):6–12

    Article  PubMed  Google Scholar 

  28. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13:795–808

    Article  PubMed  CAS  Google Scholar 

  29. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1–20

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work is supported by research grants from National Medical Research Council of Singapore (NMRC/0985/2005 and NMRC/1029/2006). We are grateful to staff in Melbourne University for their support for attachment of Jacky Loa in our Lab. The authors also like to thank the staff in Department of Experimental Surgery, Singapore General Hospital, for their support and assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kai Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loa, J., Chow, P. & Zhang, K. Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother Pharmacol 63, 1007–1016 (2009). https://doi.org/10.1007/s00280-008-0802-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-008-0802-y

Keywords

Navigation